This Web Site is owned by AMAG Pharmaceuticals, Inc. Lexington, Massachusetts, USA (“AMAG”) and operated either by us or by a third party with whom we have contracted to host this website for us. The information provided on this Web Site is for general informational and educational purposes only.
A Note about Children
AMAG does not intend to collect personally identifiable information from children under 18 years old. At any time, any person (including the parent or guardian of such child whose information was provided to AMAG) aware of AMAG having been provided personally identifiable information of a child under the age of 18 may contact us at LegalDept@amagpharma.com.
A Note to Users Outside of the United States
Types of Data We Receive
We collect Personal Information and Anonymous Data from you when you visit our site and when you send us information or communications. “Personal Information” means data that allows someone to identify or contact you, including, for example, your name, address, telephone number, e-mail address, as well as any other non-public information about you that is associated with or linked to any of the foregoing data such as your gender and nationality. “Anonymous Data” means data that is not associated with or linked to your Personal Information; Anonymous Data does not permit the identification of individual persons. We collect Personal Information and Anonymous Data, as described below.
We collect Personal Information from you, such as first and last name, gender, e-mail and mailing addresses, telephone number, as well as gender and nationality when you sign up for certain newsletters, updates or request certain information from us. This is information that you choose to provide to us. You are not required to provide such Personal Information to us, but if you do not we may not send you certain information.
We may also receive Personal and/or Anonymous Data about you from other sources like telephone or fax, or from companies that provide our products or services by way of a co-branded or private-labeled website or companies that offer their products and/or services on our website (“Third Party Companies”). We may add this information to the information we have already collected from you via our website in order to improve the products and services we provide.
Information Collected via Technology
To make our Site more useful to you, our servers (which may be hosted by a third party service provider) collect information from you, including browser type, operating system, Internet Protocol (IP) address (a number that is automatically assigned to your computer when you use the Internet, which may vary from session to session), domain name, and/or a date/time stamp for your visit. Some of this may be Personal Information and some may be Anonymous Data. AMAG also uses customized software, which may include software that passively collects certain data about your visits to the Site, such as your IP address, the browser version your computer is operating and the time of day you access the Site.
We may allow selected third parties to place cookies through the Site to provide us with better insights into the use of the Site or user demographics or to provide relevant advertising to you. These third parties may collect information about a consumer’s online activities over time and across different websites when he or she uses our website. We may also permit third party service providers to place cookies through our Site to perform analytic or marketing functions where you are notified of them and you have consented to the usage. We do not control the use of such third party cookies or the resulting information and we are not responsible for any actions or policies of such third parties.
We do not use technology that recognizes a “do-not-track” signal from your web browser.
Use of Your Data
Disclosure of Your Personal Information
Your Choices Regarding Your Personal Information
Changes to Personal Information
You can access, update and/or delete your Personal Information by contacting us at the phone number, mailing address or email provided on this website. However, even if you delete or change your Personal Information, it may still be stored on other databases, including those kept for archival purposes. Please also note that we may be required (by law or otherwise) to keep this information and not delete it (or to keep this information for a certain time, in which case we will comply with your deletion request only after we have fulfilled such requirements).
Security of Your Personal Information
We use reasonable technical, administrative and physical measures to protect Personal Information from unauthorized access, use, or disclosure. Even though we have taken steps to protect your Personal Information from being intercepted, accessed, used, or disclosed by unauthorized persons, we cannot fully eliminate security risks associated with Personal Information.
Links to Third Parties’ Sites
Makena (hydroxyprogesterone caproate injection) is a prescription hormone medicine (progestin) used to lower the risk of preterm birth in women who are pregnant with one baby and who have delivered one baby too early (preterm) in the past. Makena was shown to work based on a lower number of women who delivered babies at less than 37 weeks of pregnancy. There are no studies showing Makena reduces the number of babies who have serious problems shortly after birth or who die. It is not known whether Makena is safe and effective in women who have other risk factors for preterm birth.
Makena should not be used in women with any of the following conditions: blood clots or other blood clotting problems, breast cancer or other hormone-sensitive cancers, or history of these conditions; unusual vaginal bleeding not related to your current pregnancy, yellowing of the skin due to liver problems during pregnancy, liver problems, including liver tumors, or uncontrolled high blood pressure.
Before you receive Makena, tell your healthcare provider if you have an allergy to hydroxyprogesterone caproate, castor oil, or any of the other ingredients in Makena; diabetes or prediabetes, epilepsy, migraine headaches, asthma, heart problems, kidney problems, depression, or high blood pressure.
In a clinical study, certain complications or events associated with pregnancy occurred more often in women who received Makena. These included miscarriage (pregnancy loss before 20 weeks of pregnancy), stillbirth (fetal death occurring during or after the 20th week of pregnancy), hospital admission for preterm labor, preeclampsia (high blood pressure and too much protein in your urine), gestational hypertension (high blood pressure caused by pregnancy), gestational diabetes, and oligohydramnios (low amniotic fluid levels).
Makena may cause serious side effects including blood clots, allergic reactions, depression, and yellowing of your skin and the whites of your eyes. Call your healthcare provider right away if you think you have symptoms of a blood clot (leg swelling, redness in your leg, a spot on your leg that is warm to touch, or leg pain that worsens when you bend your foot) or symptoms of an allergic reaction (hives, itching, or swelling of the face). The most common side effects of Makena include injection site reactions (pain, swelling, itching, bruising, or a hard bump), hives, itching, nausea, and diarrhea.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Please see full prescribing information for Makena.